52-week range
Price risk
Balance sheet & cash
What is the price implying?
At a P/E of 62.1x, the price would imply about 29.1%/yr earnings growth for 10 years under the same assumptions, but it is not ranked.
Fewer than six years of annual earnings are available, which is too little to measure delivered growth.
“Implied growth” is what the current price would require under our stated assumptions, not what we expect.
What prices imply across Finance The market-wide Expectations lists
What changed?
- Oct '26Volume reached 16.1x its 50-day median on 2026-10-12; price +4.8% that day.
- Jul '26Volume reached 36.2x its 50-day median on 2026-07-21; price +7.1% that day.
- Jun '26Volume reached 29.2x its 50-day median on 2026-06-03; price +2.8% that day.
- May '26Regained the 2025-11 peak, 2 months after the low.
- Mar '26Fell 27% from the Nov 2025 peak to the Mar 2026 low.
- Mar '26Volume reached 43.4x its 50-day median on 2026-03-27; price -2.4% that day.
- Dec '25Volume reached 25.2x its 50-day median on 2025-12-22; price +0.1% that day.
Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.
Where price and fundamentals disagree, market-wide Rewind the whole market to any month
Are profits backed by cash?
2 of 4 checks are within range, 2 beyond a threshold.
Tap a check to see how it is measured.
Other income reliance8%Within range
Other income as a share of pre-tax profit (trailing twelve months): 7.9%. Bands: below 15%, 15% to 35%, above 35%.
Tax rate25%Within range
Median quarterly effective tax rate over about 2.5 years: 25.0%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.
Cash conversion-1.00xBeyond threshold
Operating cash flow divided by net profit over the last three fiscal years: -1.00x (cash from operations ₹-55 cr, net profit ₹55 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.
Free cash flow0 of 5 yrsBeyond threshold
Fiscal years with positive free cash flow in the last 5: 0. Bands: at least 80% of years, 40% to 80%, below 40%.
Receivable days vs history—Not enough data
Not enough reported data to compute this.
Capital work in progress—Not enough data
Not enough reported data to compute this.
Payable days—Not enough data
Not enough reported data to compute this.
How to read this
Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.
Who has been buying and selling?
- Since Jun 2025, FIIs trimmed 0.9 pts; DIIs added 0.9 pts.
- The number of shareholders rose from 1,088 to 1,380 (+27%) between Jun 2025 and Jun 2026.
Holdings, Jun '26
How each group changed
Number of shareholders
Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.
How rough has the ride been?
Monthly share price
Last 90 trading days
Drawdown from peak
Largest drawdowns
-26.6% (2025-11 peak to 2026-03 low, recovered 2026-05)
-17.3% (2026-05 peak to 2026-07 low, recovered 2026-07)
-16.6% (2026-08 peak to 2026-09 low, recovered 2026-10)
Most recent volume spikes
2026-10-12: 16.1x the 50-day median, price +4.8% that day
2026-08-27: 6.7x the 50-day median, price -5.1% that day
2026-08-26: 9.8x the 50-day median, price +5.8% that day
Where does it rank among Finance peers?
Each cell is the company's percentile rank among its Finance peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.
The Finance sector page Watch it move against Finance in the Observatory
What else looks like this?
Companies with the most similar financial profile today, regardless of industry.
| Company | Sector | Similarity | Closest on |
|---|---|---|---|
| RAJOO ENGINEERS (RAJOOENG) | Producer Manufacturing | 77% | ROCE, operating margin |
| JAGSONPAL PHARMACEUTICALS LIMI (JAGSNPHARM) | Health Technology | 69% | debt/equity, revenue |
| SHREE RAMA MULTI-TECH (SHREERAMA) | Process Industries | 65% | market cap, revenue |
| PREMIER POLYFILM (PREMIERPOL) | Non-Energy Minerals | 63% | ROCE, revenue |
| ZTECH INDIA (ZTECH) | Industrial Services | 61% | P/E, ROCE |
| WEALTH FIRST PORTFOLIO MGR (WEALTH) | Finance | 42% | market cap, revenue |
| DAM CAPITAL ADVISORS (DAMCAPITAL) | Finance | 32% | revenue, operating margin |
| MONARCH NETWORTH CAPITAL (MONARCH) | Finance | 32% | debt/equity, ROCE |
Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.
Monthly history (12 months)
| Month | P/E | Revenue (TTM) | ROE | ROCE | Debt / Equity |
|---|---|---|---|---|---|
| 2026-10 | 24.8x | ₹201 cr | 19.7% | 26.0% | 0.0x |
| 2026-09 | 23.6x | ₹201 cr | 19.7% | 26.0% | 0.0x |
| 2026-08 | 25.5x | ₹189 cr | 18.5% | 26.0% | 0.0x |
| 2026-07 | 26.4x | ₹189 cr | 18.5% | 26.0% | 0.0x |
| 2026-06 | 22.5x | ₹189 cr | 18.5% | 26.0% | 0.0x |
| 2026-05 | 25.0x | ₹158 cr | 21.1% | 26.0% | 0.0x |
| 2026-04 | 29.5x | ₹158 cr | 21.1% | 26.0% | 0.0x |
| 2026-03 | 22.4x | ₹158 cr | 21.1% | 26.0% | 0.0x |
| 2026-02 | 27.5x | ₹103 cr | 18.0% | 26.0% | 0.0x |
| 2026-01 | 27.6x | ₹103 cr | 18.0% | 26.0% | 0.0x |
| 2025-12 | 29.1x | ₹103 cr | 18.0% | 26.0% | 0.0x |
| 2025-11 | 30.7x | ₹103 cr | 18.0% | 26.0% | 0.0x |